MannKind Corp (MNKD)
4.62
+0.15
(+3.36%)
USD |
NASDAQ |
Mar 18, 16:00
4.66
+0.04
(+0.87%)
After-Hours: 20:00
MannKind Cash from Financing (TTM): 136.61M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 136.61M |
September 30, 2023 | -2.249M |
June 30, 2023 | 17.56M |
March 31, 2023 | 21.73M |
December 31, 2022 | 21.39M |
September 30, 2022 | 115.93M |
June 30, 2022 | 95.82M |
March 31, 2022 | 46.10M |
December 31, 2021 | 270.27M |
September 30, 2021 | 191.59M |
June 30, 2021 | 194.82M |
March 31, 2021 | 274.50M |
December 31, 2020 | 49.85M |
September 30, 2020 | 36.20M |
June 30, 2020 | 99.06M |
March 31, 2020 | 70.19M |
December 31, 2019 | 69.86M |
September 30, 2019 | 100.79M |
June 30, 2019 | 33.47M |
March 31, 2019 | 60.77M |
December 31, 2018 | 61.29M |
September 30, 2018 | 83.57M |
June 30, 2018 | 85.37M |
March 31, 2018 | 74.17M |
December 31, 2017 | 73.56M |
Date | Value |
---|---|
September 30, 2017 | 15.44M |
June 30, 2017 | 10.33M |
March 31, 2017 | 42.50M |
December 31, 2016 | 43.04M |
September 30, 2016 | 91.93M |
June 30, 2016 | 43.85M |
March 31, 2016 | 4.946M |
December 31, 2015 | 5.668M |
September 30, 2015 | -45.01M |
June 30, 2015 | 39.44M |
March 31, 2015 | 67.88M |
December 31, 2014 | 70.06M |
September 30, 2014 | 88.93M |
June 30, 2014 | 156.12M |
March 31, 2014 | 149.39M |
December 31, 2013 | 145.67M |
September 30, 2013 | 216.70M |
June 30, 2013 | 122.79M |
March 31, 2013 | 92.78M |
December 31, 2012 | 179.58M |
September 30, 2012 | 91.72M |
June 30, 2012 | 121.86M |
March 31, 2012 | 140.12M |
December 31, 2011 | 63.39M |
September 30, 2011 | 78.24M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-2.249M
Minimum
Sep 2023
274.50M
Maximum
Mar 2021
95.21M
Average
70.03M
Median
Cash from Financing (TTM) Benchmarks
United Therapeutics Corp | -11.90M |
Corcept Therapeutics Inc | -148.72M |
Cassava Sciences Inc | 2.56M |
Amphastar Pharmaceuticals Inc | 454.09M |
Cogent Biosciences Inc | 163.54M |